Locations:
Search
For the second straight year, Dr. Vince has been recognized by Becker's Healthcare as one of the top 35 chief innovation officers to know.
XR90 is intended to be used adjunctively for minimally invasive ultrasound and CT-guided needle-based procedures for soft tissue and bone.
VisionAir Solutions creates patient-specific airway stents with its 3D-design platform.
Proven technology in 700 patients granted Breakthrough Device designation from the FDA.
Margot Damaser, PhD, Cleveland Clinic Lerner Research Institute, shares her inventor journey.
Cleveland Clinic Innovations team members from Ventures, Engagement, and Business Development & Licensing attend this year's HLTH conference in Las Vegas.
Stanley Hazen, MD, PhD, founder of Zehna Therapeutics, a Cleveland Clinic Innovations portfolio company has been focusing on the relationship between heart and metabolic health for much of his 25 years at Cleveland Clinic. Inhibitors that target gut microbial enzymes are likely the key to treating a variety of cardiovascular diseases, some of which have no other cure.
Health system venture fund leaders discussed their investment strategy, how it changed during the pandemic, and their plans for the post-PHE era.
The Proof of Concept Office is pleased to announce the new class of Innovation Fellows.
